Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B

被引:8
|
作者
Saito, T
Shinzawa, H
Uchida, T
Kawamata, O
Honma, S
Watanabe, H
Shao, L
Saito, K
Togashi, H
Takahashi, T
机构
[1] Yamagata Univ, Sch Med, Dept Internal Med, Yamagata 9909585, Japan
[2] Nihon Univ, Sch Med, Dept Pathol, Tokyo, Japan
[3] SRL Inc, Ctr Mol Biol & Cytogenet, Hepatitis Virus Anal Sect, Tokyo, Japan
关键词
silent B; HBV mutant; X gene; PCR; quantitation;
D O I
10.1002/(SICI)1096-9071(199908)58:4<325::AID-JMV2>3.0.CO;2-L
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Low-level viremia due to hepatitis B virus (HBV) was demonstrated in the sera of two patients diagnosed previously as having non-B, non-C chronic hepatitis. Both patients had a "silent" HBV infection, because they were negative for both hepatitis:B surface antigen (HBsAg) and anti-hepatitis B core antibody. The TaqMan chemistry polymerase chain reaction (PCR) amplified the HBV DNA, enabling quantitation of the virus in their sera. Their serum HBV DNA concentrations were low: the amount of each HBV S or X gene amplified showed there were approximately 10(3) copies/ml and HBV DNA was detected occasionally during clinical follow-up. Positive HBsAg staining in liver tissues was demonstrated by an immunoperoxidase technique. Vertical transmission of silent HBV from one patient to her daughter was confirmed. Direct nucleotide sequencing of the amplified HBV X region revealed several mutations, suggesting reduced viral replication. One patient had a T-to-C mutation at the extreme 5'-terminus of the direct repeat 2 region and the other exhibited a coexisting X region with a 155-nucleotide deletion. These findings suggest that HBV replication is suppressed considerably in patients with silent hepatitis B. J. Med. Virol. 58: 325-331 1999. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:325 / 331
页数:7
相关论文
共 50 条
  • [21] IMPROVEMENTS OF EFFICACY AND SAFETY PROFILES OF TENOFOVIR AMIBUFENAMIDE IN CHRONIC HEPATITIS B PATIENTS WITH MAINTAINED VIROLOGICAL RESPONSE OR LOW-LEVEL VIREMIA
    Liu, Zhihong
    Jin, Qinglong
    Zhang, Yuexin
    Gong, Guozhong
    Wu, Guicheng
    Yao, Lvfeng
    Wen, Xiaofeng
    Gao, Zhiliang
    Huang, Yan
    Yang, Daokun
    Chen, Enqiang
    Mao, Qing
    Lin, Shide
    Shang, Jia
    Gong, Huanyu
    Zhong, Lihua
    Yin, Huafa
    Wang, Fengmei
    Hu, Peng
    Wu, Qiong
    Pan, Chao
    Jia, Wen
    Li, Chuan
    Niu, Junqi
    Hou, Jinlin
    HEPATOLOGY, 2024, 79 (02) : E63 - E64
  • [22] New therapeutic options for persistent low-level viremia in patients with chronic hepatitis B virus infection: Increase of entecavir dosage
    Guo-Qing Yin
    Jun Li
    Bei Zhong
    Yong-Fong Yang
    Mao-Rong Wang
    World Journal of Gastroenterology, 2021, 27 (08) : 666 - 676
  • [23] New therapeutic options for persistent low-level viremia in patients with chronic hepatitis B virus infection: Increase of entecavir dosage
    Yin, Guo-Qing
    Li, Jun
    Zhong, Bei
    Yang, Yong-Fong
    Wang, Mao-Rong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (08) : 666 - 676
  • [24] Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection
    Chu, CM
    Sheen, IS
    Liaw, YF
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (08) : 778 - 782
  • [25] Analysis on clinical features and immunity in chronic hepatitis B virus infected patients with low-level HBsAg
    Cheng, Jun
    Sun, Changgui
    Chen, Yu
    Xu, Zhiliang
    Wang, Guozheng
    Sun, Guanzhong
    Li, Xiaojun
    AFRICAN JOURNAL OF MICROBIOLOGY RESEARCH, 2010, 4 (07): : 547 - 550
  • [26] INCIDENCE AND RISK FACTORS FOR LOW LEVEL VIREMIA IN CHRONIC HEPATITIS B PATIENTS RECEIVING ANTIVIRAL TREATMENT
    Hasanoglu, Imran
    Guner, Hatice Rahmet
    Zerdali, Esra Yerlikaya
    Tosun, Selma
    Onlen, Yusuf
    Yildirim, Figen
    Turunc, Tuba
    Gunal, Ozgur
    Batirel, Ayse
    Kaya, Selcuk
    Ozkaya, Deniz
    Altunal, Nilsun
    Tabak, Fehmi
    HEPATOLOGY, 2023, 78 : S527 - S527
  • [27] Risk factors for very low-level viremia in patients with chronic hepatitis B virus infection: A single-center retrospective study
    Lu, Jiahui
    Zhang, Congnan
    He, Pengyuan
    Ou, Mengdang
    Xia, Jinyu
    Huang, Mingxing
    LIVER RESEARCH, 2022, 6 (01) : 39 - 44
  • [28] Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia
    Paik, Namyoung
    Sinn, Dong H.
    Lee, Ji H.
    Oh, In S.
    Kim, Jung H.
    Kang, Wonseok
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon S.
    Lee, Joon H.
    Koh, Kwang C.
    Paik, Seung W.
    LIVER INTERNATIONAL, 2018, 38 (01) : 68 - 75
  • [29] CLINICAL OUTCOMES OF INACTIVE HEPATITIS B SURFACE ANTIGEN CARRIERS WITH UNDETECTABLE HBV DNA LEVELS AND LOW-LEVEL VIREMIA
    Pan, Yifan
    Wang, Jian
    Zhang, Shaoqiu
    Zhu, Li
    Zhang, Zhiyi
    Li, Yuanyuan
    Xiong, Ye
    Fan, Tao
    Zhu, Chuanwu
    Li, Jie
    Liu, Xingxiang
    Huang, Rui
    Chao, Wu
    HEPATOLOGY, 2024, 80 : S540 - S541
  • [30] Importance of Combined Fibrosis Indices in Chronic Hepatitis B Patients With Low Viremia
    Sertoglu, Erdim
    Kayadibi, Huseyin
    Uyanik, Metin
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (02) : 170 - 171